BGV (BioGeneration Ventures)

Amsterdam, Netherlands
Founded:2006
Firm Location:Amsterdam, Netherlands • Netherlands • Naarden, Netherlands
Investor Firms That Co-Invest with BGV (BioGeneration Ventures)
BGV (BioGeneration Ventures) Team
Photo of Diede Brunen, Senior Associate at BGV (BioGeneration Ventures)
Diede Brunen
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Daniela Couto, Partner at BGV (BioGeneration Ventures)
Daniela Couto
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Rob de Ree, Venture Partner at BGV (BioGeneration Ventures)
Rob de Ree
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Arnoud Dijkstra, Venture Partner at BGV (BioGeneration Ventures)
Arnoud Dijkstra
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Rianne Ellenbroek, Investor at BGV (BioGeneration Ventures)
Rianne Ellenbroek
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Keno Gutierrez, Partner at BGV (BioGeneration Ventures)
Keno Gutierrez
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Joost Holthuis, Venture Partner at BGV (BioGeneration Ventures)
Joost Holthuis
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Max Klement, Principal at BGV (BioGeneration Ventures)
Max Klement
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Oscar Slotboom, General Partner at BGV (BioGeneration Ventures)
Oscar Slotboom
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Edward Van Wezel, Managing Partner at BGV (BioGeneration Ventures)
Edward Van Wezel
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Wouter Verhoeven, Venture Partner at BGV (BioGeneration Ventures)
Wouter Verhoeven
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Alexander Vos, Venture Partner at BGV (BioGeneration Ventures)
Alexander Vos
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Pharmaceuticals, Investors in Pharmaceuticals